JP Morgan Chase’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-175,500
Closed -$2.68M 8010
2026
Q1
$2.68M Buy
+175,500
New +$4.31M ﹤0.01% 3885
2025
Q2
Sell
-75,000
Closed -$2.62M 7527
2025
Q1
$2.62M Buy
+75,000
New +$3.06M ﹤0.01% 3669
2023
Q1
Sell
-100,800
Closed -$8.64M 7129
2022
Q4
$8.64M Buy
+100,800
New +$8.54M ﹤0.01% 2392
2022
Q1
Sell
-80,900
Closed -$10.9M 6931
2021
Q4
$10.9M Buy
+80,900
New +$11.3M ﹤0.01% 2372
2021
Q1
Sell
-120,000
Closed -$21.6M 6288
2020
Q4
$21.6M Buy
+120,000
New +$26.7M ﹤0.01% 1561
2017
Q4
Sell
-15,600
Closed -$688K 5548
2017
Q3
$688K Buy
+15,600
New +$543K ﹤0.01% 3698

Other funds holding QDEL

JP Morgan Chase's QDEL Position: Q2 2026 in Review

JP Morgan Chase reduced its QuidelOrtho (QDEL) stake by 7.3% in Q2 2026, selling an estimated $132K and leaving 126,724 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #4090.

JP Morgan Chase first reported a position in QDEL in Q3 2013 and has held it in 45 quarters since. The position peaked at $107M in Q1 2023. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • JP Morgan Chase held 126,724 shares of QuidelOrtho worth $2.31M as of Q2 2026.
  • JP Morgan Chase sold 10,012 QuidelOrtho shares in Q2 2026, an estimated $132K.
  • QuidelOrtho made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4090 holding.
  • JP Morgan Chase first reported a position in QuidelOrtho in Q3 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's QuidelOrtho position peaked at $107M in Q1 2023.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.